药品授权模式与经济价值的相关性研究-AtlantisPress.PDFVIP

Advances in Social Science, Education and Humanities Research, volume 264 5th International Conference on Education, Management, Arts, Economics and Social Science (ICEMAESS 2018) An Empirical Study on the Impact of drug licensing on sales Wang Qihang1, a, Cao Chen2, b, Hu Yuanjia2, c 1Chongqing College of Electronic Engineering, Chongqing, China 2Institute of Chinese Medical Sciences, University of Macau, Macau,China a b c wang_qihang@126.com, krt- 1979@163.com, huyuanjia@ Keywords: drug licensing; sales; T-test; Q-test Abstract: To study the impact of drug licensing on its sales, and to provide a reference for drug development and corporation between pharma. METHODS: Based on the variables “license station”, “co-development or co-marketing”, “licensor in accord with key marketing company or not” and “time for drug licensing” which reflected drug licensing and sales, with SPSS statistical software, T-test and Q-test of drug licensing and the sales of drugs were carried out on the 151 sample drugs collected in IMS Health. RESULTS CONCLUSIONS: Drugs with licensing activities have higher sales than those without licensing. There is no significant difference between co-development and co-marketing for the drugs, Licensor hold the key marketing right helps improve sales of drugs. The optimum time for drug licensing is phase Ⅲ. 1. Purpose of research Drug licensing is a common way used by pharmaceutical enterprises, including the transfer of molecular entities, technology, patent development transference, production and marketing rights [1]